常用抗肿瘤中成药治疗肺癌临床研究进展  

Review of Commonly used Chinese Patent Medicine on Treatment of Lung Cancer

作　　者：陈果[1] 王雄彪[1] 

机构地区：[1]上海中医药大学附属普陀医院呼吸内科,上海200062

出　　处：《辽宁中医药大学学报》2012年第3期63-67,共5页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：上海市教育委员会科研创新项目(30872553);上海市科学技术委员会科研计划项目(08ZR1420900);上海市科学技术委员会科研计划项目(09JC1412900)

摘　　要：肺癌是当前世界各地最常见的恶性肿瘤之一,现代医学对该病总的治愈率低,中医药疗法是我国治疗肺癌的特色,发挥着其在治疗肺癌以病灶稳定性高、毒副反应低、生存质量优为特点;其中,中成药发挥着极大的优势,在抗肿瘤、增强患者免疫力、降低放化疗毒副反应、改善患者临床症状、改善生活质量等方面成绩突出,现就近年来常用抗肿瘤中成药治疗肺癌的临床研究进展做一综述。Lung cancer is currently one of the most prevalent types of cancer worldwide,with low survival rate.Traditional Chinese medicine characterized by high quality of life and low side effects has proved to be effective for lung cancer treatment,in which Chinese patent medicine plays very important roles.Chinese patent medicine has significant effect in enhancing immunity of patients,reducing chemotherapy side effects,improving clinical symptoms,improving quality of life.This paper comprehensive discusses the recent use of Chinese patent medicine in clinical anti cancer research.

关 键 词：中成药 肺癌 综述 

分 类 号：R734.2[医药卫生—肿瘤]